These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol. Levenson AJ, Burnett GB, Nottingham JD, Sermas CE, Thornby JI. Curr Ther Res Clin Exp; 1976 Nov; 20(5):695-700. PubMed ID: 825356 [No Abstract] [Full Text] [Related]
3. Computerized EEG: predictor of outcome in schizophrenia. Itil TM, Marasa J, Saletu B, Davis S, Mucciardi AN. J Nerv Ment Dis; 1975 Mar; 160(3):118-203. PubMed ID: 1090708 [Abstract] [Full Text] [Related]
4. Thiothixene in childhood psychoses. Simeon J, Saletu B, Saletu M, Itil TM, DaSilva J. Adv Biochem Psychopharmacol; 1974 Mar; 9(0):519-34. PubMed ID: 4599439 [No Abstract] [Full Text] [Related]
5. Haloperidol and thiothixene in the long-term treatment of chronic schizophrenic outpatients in an urban community: social and vocational adjustment. Engelhardt DM, Rudorfer L, Rosen B. J Clin Psychiatry; 1978 Dec; 39(12):834-40. PubMed ID: 721787 [Abstract] [Full Text] [Related]
6. Relative efficacy of parenteral haloperidol and thiothixene for the emergency treatment of acutely excited and agitated patients. Stotsky BA. Dis Nerv Syst; 1977 Dec; 38(12):967-73. PubMed ID: 338270 [Abstract] [Full Text] [Related]
10. The efficacy and safety of loxapine succinate in the treatment of schizophrenia: a comparative study with thiothixene. Vianna Filho U, Versiani Caldeira V, Romildo Bueno J. Curr Ther Res Clin Exp; 1975 Sep; 18(3):476-90. PubMed ID: 810308 [No Abstract] [Full Text] [Related]
12. A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics. Hall WB, Vestre ND, Schiele BC, Zimmermann R. Dis Nerv Syst; 1968 Jun; 29(6):405-8. PubMed ID: 4877748 [No Abstract] [Full Text] [Related]
13. Rapid tranquilization: a comparative study of thiothixene and haloperidol. Kelwala S, Ban TA, Berney SA, Wilson WH. Prog Neuropsychopharmacol Biol Psychiatry; 1984 Jun; 8(1):77-83. PubMed ID: 6145189 [Abstract] [Full Text] [Related]
14. Blood levels of neuroleptics: state of the art. Simpson GM, Yadalam K. J Clin Psychiatry; 1985 May; 46(5 Pt 2):22-8. PubMed ID: 2859277 [Abstract] [Full Text] [Related]
15. Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population. Martin IC. Acta Psychiatr Scand; 1975 Feb; 51(2):110-8. PubMed ID: 235189 [Abstract] [Full Text] [Related]
16. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. Serban G, Siegel S. Am J Psychiatry; 1984 Nov; 141(11):1455-8. PubMed ID: 6388363 [Abstract] [Full Text] [Related]
17. A comparison of haloperidol and thioridazine HC1 in chronic treatment-resistant schizophrenics. Gonier T, Schiele BC, Vestre ND. Behav Neuropsychiatry; 1970 Nov; 2(3):47-9 passim. PubMed ID: 4913152 [No Abstract] [Full Text] [Related]
18. Haloperidol for chronically hospitalized psychotics: a double-blind comparison with thiothixene and placebo; a follow-up open evaluation. Howard JS. Dis Nerv Syst; 1974 Oct; 35(10):458-63. PubMed ID: 17894059 [No Abstract] [Full Text] [Related]
19. Effectiveness of loxapine succinate in acute schizophrenia: a comparative study with thiothixene. van der Velde CD, Kiltie H. Curr Ther Res Clin Exp; 1975 Jan; 17(1):1-12. PubMed ID: 806422 [No Abstract] [Full Text] [Related]
20. Thiothixene in the treatment of diseases of the senium. Birkett DP, Hirschfield W, Simpson GM. Curr Ther Res Clin Exp; 1972 Dec; 14(12):775-9. PubMed ID: 4629816 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]